✦ LIBER ✦

O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC

✍ Scribed by Lynch, Thomas James; Raju, R.; Lind, M.; Riviere, A.; Gatzemeier, U.; Dorr, A.; Holmlund, J.; Yuen, A.; Sikic, B.

Book ID: 118571499
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 189 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91766-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of chemotherapy in elderly pa

Management of chemotherapy in elderly patients with advanced non small cell lung cancer (NSCLC): A phase III randomized trial

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 167 KB

A Phase I trial of h-ras antisense oligo

A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma

✍ C. Casey Cunningham; Jon T. Holmlund; Richard S. Geary; T. Jesse Kwoh; Andrew Do 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

O-086 A phase III randomized trial of ca

O-086 A phase III randomized trial of carboplati/paclitaxel, with or without bexarotene (Targretin®), in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Gatzemeier, U.; Blumenschein, G.; Jotte, R.; von Pawel, J.; Miller, W.; Khuri, E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Phase III Randomized Trial of Induction

Phase III Randomized Trial of Induction Chemotherapy in Patients With N2 or N3 Locally Advanced Head and Neck Cancer

✍ Cohen, E. E. W.; Karrison, T. G.; Kocherginsky, M.; Mueller, J.; Egan, R.; Huang 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 272 KB

O-085 Phase III trial of the protein kin

O-085 Phase III trial of the protein kinase C α (PKCα) antisense oligonucleotide Aprinocarsen plus gemcitabine/cisplatin versus gemcitabine/cisplatin alone in advanced stage non-small cell lung cancer (NSCLC): Updated results of a randomized phase III trial

✍ Gandara, D.; Douillard, J.; Koralewski, P.; Manegold, C.; Smit, E.; Reyes, J.; C 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB

O-082 A randomized phase III trial compa

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB